Cyclacel pharmaceuticals to participate in march investor conferences

Berkeley heights, n.j., march 07, 2023 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; "cyclacel" or the "company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced today that the company plans to participate in a fireside chat and host one-on-one meetings at two investor conferences.
CYCC Ratings Summary
CYCC Quant Ranking